Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostatic Neoplasms, Locally Advanced”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02001623
What this trial is testing

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Who this might be right for
Ovary CancerCervix CancerEndometrium Cancer+5 more
Seagen Inc. 195
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623642
What this trial is testing

A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.

Who this might be right for
Uterine Cervical NeoplasmsTriple Negative Breast NeoplasmsProstatic Neoplasms+8 more
GV20 Therapeutics 227
Early research (Phase 1)Looking for participantsNCT07540572
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

Who this might be right for
ER+, HER 2- Breast CancerNon-small Cell Lung Cancer (NSCLC)Castration-resistant Prostate Cancer (CRPC)+1 more
IDEAYA Biosciences 160
Not applicableStudy completedNCT03350529
What this trial is testing

MRI Guided Transurethral HIFU for Various Prostate Diseases

Who this might be right for
Localised Prostate CancerLocally Advanced Prostate CancerLocally Recurrent Prostate Cancer+1 more
Turku University Hospital 87
Testing effectiveness (Phase 2)Ended earlyNCT04032704
What this trial is testing

Ladiratuzumab Vedotin in Advanced Solid Tumors

Who this might be right for
Small Cell Lung CancerNon-small Cell Lung Cancer, SquamousNon-small Cell Lung Cancer, Non-squamous+6 more
Seagen Inc. 205
Early research (Phase 1)Study completedNCT02014337
What this trial is testing

Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors

Who this might be right for
Breast CancerOvarian Epithelial Cancer RecurrentSarcoma+4 more
Corcept Therapeutics 37
Not applicableStudy completedNCT01123434
What this trial is testing

Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.

Who this might be right for
2 Years PSA Recurrence Rate
AstraZeneca 200
Not applicableLooking for participantsNCT04543799
What this trial is testing

Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer

Who this might be right for
Prostate CancerBreast Cancer
Oncology Institute of Southern Switzerland 60
Not applicableNot Yet RecruitingNCT04093375
What this trial is testing

Radical Prostatectomy Versus Radical Radiotherapy for Locally Advanced Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Tongji Hospital 600
Early research (Phase 1)Active Not RecruitingNCT03582475
What this trial is testing

Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate

Who this might be right for
Bladder Small Cell Neuroendocrine CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Bladder Urothelial Carcinoma+14 more
Jonsson Comprehensive Cancer Center 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07730151
What this trial is testing

Efficacy and Safety of Darolutamide Combined With Docetaxel and ADT as Neoadjuvant Therapy for Locally Advanced Prostate Cancer.

Who this might be right for
Prostate CancerProstateProstate Cancer Patients
RenJi Hospital 200
Early research (Phase 1)Study completedNCT01420250
What this trial is testing

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 20
Not applicableStudy completedNCT06217770
What this trial is testing

Retrospective Study to Assess Real-Life Use of The Long Acting GnRH Agonist as Prostate Cancer Treatment

Who this might be right for
Prostate Cancer
Chinese University of Hong Kong 237
Testing effectiveness (Phase 2)UnknownNCT03924466
What this trial is testing

Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients

Who this might be right for
Metastatic Breast CarcinomaLocally Advanced Breast CancerCancer of Pancreas+11 more
Universitair Ziekenhuis Brussel 55
Not applicableStudy completedNCT02853409
What this trial is testing

Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Ipsen 628
Early research (Phase 1)Looking for participantsNCT06440005
What this trial is testing

Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Who this might be right for
CancerAdvanced CancerLocally Advanced Carcinoma+8 more
Angiex, Inc. 80
Testing effectiveness (Phase 2)Study completedNCT00242138
What this trial is testing

Erectile Dysfunction/Prostate/RT/Androgen

Who this might be right for
Prostatic Neoplasms
University Health Network, Toronto 50
Large-scale testing (Phase 3)Study completedNCT05590793
What this trial is testing

Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate

Who this might be right for
Advanced Prostate CancerMetastatic Prostate CancerLocally Advanced Prostate Cancer
Ipsen 195
Not applicableLooking for participantsNCT02971358
What this trial is testing

Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastatic Prostate Cancer

Who this might be right for
Locally Advanced and Metastatic Prostate Cancer
Medical University of Vienna 200
Early research (Phase 1)UnknownNCT01048151
What this trial is testing

TNFerade Biologic to Treat Locally Advanced Prostate Cancer

Who this might be right for
Locally Advanced Prostate Cancer
GenVec 20
Next Page